IIM
ADCT icon

INTECH Investment Management’s ADC Therapeutics ADCT Stock Holding History

INTECH Investment Management’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$90K Sell
23,988
-12,952
-35% -$51.1K ﹤0.01% 1912
2025
Q4 		$130K Buy
36,940
+759
+2% +$3.08K ﹤0.01% 2102
2025
Q3 		$145K Hold
36,181
– – ﹤0.01% 2163
2025
Q2 		$97K Sell
36,181
-26,691
-42% -$56.1K ﹤0.01% 2302
2025
Q1 		$88.7K Buy
62,872
+24,437
+64% +$41.5K ﹤0.01% 2344
2024
Q4 		$76.5K Buy
38,435
+25,437
+196% +$66.6K ﹤0.01% 2265
2024
Q3 		$40.9K Buy
+12,998
New +$41K ﹤0.01% 1997

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return